Requested blood tests
Commission directive 2006/17/EC regarding certain technical requirements for the donation, procurement and testing of human tissues and cells
Starting June 1, 2009, Reprofit International is implementing practices and precautions necessary for artificial insemination treatments within the entire European Union.
Complying with these practices will contribute to higher quality of care and coordination with other countries.
Practically it means a rigorous laboratory verification whether or not the patient is a carrier of sexually transmitted diseases and adoption of more strict criteria for cryopreservation of embryos and sperm. Reprofit International has also achieved a license for import and export of human gametes and embryos within the European Union and beyond.
Each patient is now required, on the day of open manipulation with his/her reproductive cells (eggs and sperm), to have their blood drawn and tested for the following infections: viral- HIV 1 & 2, Hepatitis B &C; and bacterial – Treponema Pallidum (Syphilis). It is necessary to collect a blood sample from all female patients before their egg retrieval and all male partners before using their sperm for IVF or ICSI (doesn’t apply to intrauterine insemination (IUI)).
Starting October, 2011, there will be changes to the laboratory procedures for infectious disease testing, that is required by Czech law.
As a result of these changes, there will be an increase in cost for the tests. The cost has been set at 100 Euros.
Test results will be sent to all patients via email within 14 days.
Thank you for your understanding and cooperation.
Marek Koudelka, M.D.
Managing Director of Reprofit International